EVENTIDE ASSET MANAGEMENT, LLC
BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$7.14B2026 Q3
Positions347
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.23.1%
What Changed This Quarter?
Top Holdings
GH
Guardant Health
4.6%
XMTR
Xometry
3.1%
TT
Trane Technologies
2.7%
LRCX
Lam Research
2.6%
TRGP
Targa Resources
1.9%
BBNX
Beta Bionics
1.9%
ASML
Asml
1.7%
URI
United Rentals
1.6%
New / Increased
64 new · 205 increased
PLDNEW
Prologis
1.0%
AGENNEW
Agenus
0.3%
ALABNEW
Astera Labs
0.3%
DLRNEW
Digital Rlty Tr
0.3%
REPLNEW
Replimune
0.3%
NOW
ServiceNow
0.4%
+1177.0%
CLDX
Celldex Therapeutics
0.9%
+82.9%
TYL
Tyler Technologies
0.4%
+5007.3%
Reduced / Exited
67 reduced · 18 sold out
RBA
RB Global
0.0%
-99.4%
LRCX
Lam Research
2.6%
-15.3%
KLAC
Kla
0.5%
-48.1%
DELL
Dell Technologies
1.0%
-31.6%
GEV
Ge Vernova
1.0%
-28.5%
Apogee Therap…EXIT
Apogee Therapeutics
0.5%
BBIOEXIT
Bridgebio Pharma
0.4%
AMLXEXIT
Amylyx Pharmaceuticals
0.3%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.